Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome from Non-Controlling InterestsIncome towards Parent CompanyInterest ExpensesInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeNon Operating Investment IncomeNon Operating Investment IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRent ExpenseRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax RateTax Rate
Others
Ratios

National Healthcare Properties (HLTC) EBITDA (2016 - 2025)

National Healthcare Properties has reported EBITDA over the past 13 years, most recently at -$27.9 million for Q4 2025.

  • For Q4 2025, EBITDA fell 54.36% year-over-year to -$27.9 million; the TTM value through Dec 2025 reached -$82.1 million, up 60.96%, while the annual FY2025 figure was -$82.1 million, 60.96% up from the prior year.
  • EBITDA for Q4 2025 was -$27.9 million at National Healthcare Properties, down from -$17.8 million in the prior quarter.
  • Over five years, EBITDA peaked at $3.6 million in Q1 2021 and troughed at -$121.2 million in Q2 2024.
  • A 5-year average of -$25.1 million and a median of -$17.9 million in 2021 define the central range for EBITDA.
  • Biggest five-year swings in EBITDA: skyrocketed 105.83% in 2021 and later crashed 4561.68% in 2023.
  • Year by year, EBITDA stood at -$14.6 million in 2021, then tumbled by 65.96% to -$24.3 million in 2022, then tumbled by 65.48% to -$40.1 million in 2023, then soared by 54.92% to -$18.1 million in 2024, then tumbled by 54.36% to -$27.9 million in 2025.
  • Business Quant data shows EBITDA for HLTC at -$27.9 million in Q4 2025, -$17.8 million in Q3 2025, and -$26.4 million in Q2 2025.